Filing Flows › Comparisons › AMRX vs RPRX
Amneal Pharmaceuticals vs Royalty Pharma: AMRX and RPRX compared
Amneal Pharmaceuticals is the larger company: $863M of revenue in its latest quarter (Q3 2026) against $690M for Royalty Pharma (Q3 2026). Royalty Pharma is growing faster (+13% against +10% a year earlier). Royalty Pharma is more profitable, with an operating margin of 59.5% against 11.1%.
Where the money goes: AMRX and RPRX
Amneal Pharmaceuticals (AMRX) · Q3 2026
Amneal Pharmaceuticals, Q3 2026: revenue $863M (+10% year over year), operating margin 11.1%, net earnings $12.3M, operating cash flow $98.3M. The chart follows the revenue to costs, profit and cash.
Royalty Pharma (RPRX) · Q3 2026
Royalty Pharma, Q3 2026: revenue $690M (+13% year over year), operating margin 59.5%, net earnings $145M, operating cash flow $686M. The chart follows the revenue to costs, profit and cash.
| Amneal Pharmaceuticals (AMRX) | Royalty Pharma (RPRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $863M | $690M |
| Revenue growth, Y/Y | +10% | +13% |
| Gross margin | 38.7% | — |
| Operating margin | 11.1% | 59.5% |
| Net earnings | $12.3M | $145M |
| Net margin | 1.4% | 21.0% |
| Operating cash flow | $98.3M | $686M |
| Free cash flow | $66.5M | — |
| Market value | $6.6B | $37.5B |
| P/E | 30.7× | 44.3× |
| Analysts’ mean target | $23.86 | $71.25 |
Where the revenue comes from
Royalty Pharma
- Income from financial royalty assets: $648M (94%)
- Other royalty income and revenues: $42.5M (6%)
Questions
Which is bigger, Amneal Pharmaceuticals or Royalty Pharma?
Amneal Pharmaceuticals is the larger company: $863M of revenue in its latest quarter (Q3 2026) against $690M for Royalty Pharma (Q3 2026).
Is Amneal Pharmaceuticals or Royalty Pharma growing faster?
Royalty Pharma is growing faster (+13% against +10% a year earlier).
Which is more profitable, Amneal Pharmaceuticals or Royalty Pharma?
Royalty Pharma is more profitable, with an operating margin of 59.5% against 11.1%.
More: Amneal Pharmaceuticals earnings · how Amneal Pharmaceuticals makes money · Royalty Pharma earnings · how Royalty Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.